Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Multiple Sclerosis
Related studies linked through entity extraction aliases.
Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS
- Status
- COMPLETED
- Phase
- PHASE4
Upper Limbs Intervention in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Neuroretinal Biomarkers in Neurodegenerative Diseases
- Status
- COMPLETED
- Phase
- N/A
Dimethyl Fumarate (DMF) Observational Study
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)
- Status
- TERMINATED
- Phase
- PHASE1
Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion
- Status
- COMPLETED
- Phase
- NA
Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases
- Status
- COMPLETED
- Phase
- PHASE4
Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Testing the Efficacy of Self-Generation Treatment Protocol
- Status
- UNKNOWN
- Phase
- NA
Impact of CRISP on Self-Efficacy, Loneliness, and Depression
- Status
- COMPLETED
- Phase
- NA
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
- Status
- COMPLETED
- Phase
- N/A
Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic Pain
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Electrical Impedance Myography (EIM) in ALS
- Status
- COMPLETED
- Phase
- N/A
Effects of the Cross-Training in Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Effects of Dalfampridine on Cognition in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3